Targeting hepatic glucokinase in type 2 diabetes: Weighing the benefits and risks

Diabetes

Volumn 58, Issue 1, 2009, Pages 18-20

  Agius, Loranne ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE 6 PHOSPHATE; GLUCOKINASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE; HEXOKINASE; TRIACYLGLYCEROL; CARRIER PROTEIN; GLUCOKINASE REGULATORY PROTEIN;

ENZYME ACTIVITY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLYCEMIC CONTROL; GLYCOGENOLYSIS; GLYCOLYSIS; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK BENEFIT ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; ZUCKER DIABETIC FATTY RAT; ADENOVIRUS; ANIMAL; BIOLOGICAL MODEL; ENZYMOLOGY; GENETICS; LIVER; MALE; METABOLISM; RAT; ZUCKER RAT;

ADENOVIRIDAE; ANIMALS; BLOOD GLUCOSE; CARRIER PROTEINS; DIABETES MELLITUS, TYPE 2; GLUCOKINASE; GLUCOSE; LIVER; MALE; MODELS, BIOLOGICAL; RATS; RATS, ZUCKER;

EID: 63249126579     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-1470     Document Type: Note

References (20)

1. Agius L: Glucokinase and molecular aspects of liver glycogen metabolism. Biochem J 414:1-18, 2008
2. Matschinsky FM, Magnuson MA, Zelent D, Jetton TL, Doliba N, Han Y, Taub R, Grimsby J: The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes 55:1-12, 2006
3. Coghlan M, Leighton B: Glucokinase activators in diabetes management. Expert Opin Investig Drugs 17:145-167, 2008
4. Agius L: New hepatic targets for glycaemic control in diabetes. Best Pract Res Clin Endocrinol Metab 21:587-605, 2007
5. Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD, Schwenk WF, Rizza RA: Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes 49:272-283, 2000
6. Krssak M, Brehm A, Bernroider E, Anderwald C, Nowotny P, Dalla Man C, Cobelli C, Cline GW, Shulman GI, Waldhausl W, Roden M: Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. Diabetes 53:3048-3056, 2004
7. Mevorach M, Giacca A, Aharon Y, Hawkins M, Shamoon H, Rossetti L: Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. J Clin Invest 102:744-753, 1998
8. Willms B, Ben-Ami P, Soling HD: Hepatic enzyme activities of glycolysis and gluconeogenesis in diabetes of man and laboratory animals. Horm Metab Res 2:135-141, 1970
9. Caro JF, Triester S, Patel VK, Tapscott EB, Frazier NL, Dohm GL: Liver glucokinase: decreased activity in patients with type II diabetes. Horm Metab Res 27:19-22, 1995
10. Van Schaftingen E, Veiga-da-Cunha M, Niculescu L: The regulatory protein of glucokinase. Biochem Soc Trans 25:136-140, 1997
11. Shin JS, Torres TP, Catlin RL, Donahue EP, Shiota M: A defect in glucose-induced dissociation of glucokinase from the regulatory protein in Zucker diabetic fatty rats in the early stage ofdiabetes. Am JPhysiol Regul Integr Comp Physiol 292:R1381-R1390, 2007
12. Payne VA, Arden C, Lange AJ, Agius L: Contributions of glucokinase and phosphofructokinase-2/fructose bisphosphatase-2 to the elevated glycoly- sis in hepatocytes from Zucker fa/fa rats. Am J Physiol Regul Integr Comp Physiol 293:R618-R625, 2007
13. O'Doherty RM, Lehman DL, Tékémaque-Potts S, Newgard CB: Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia. Diabetes 48:2022-2027, 1999
14. Postic C, Shiota M, Magnuson MA: Cell-specific roles of glucokinase in glucose homeostasis. Recent Prog Horm Res 56:195-217, 2001
15. Torres TP, Catlin RL, Chan R, Fuijimoto Y, Sasaki N, Printz RL, Newgard CB, Shiota M: Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in Zucker diabetic fatty rats. Diabetes 58:78 -86, 2009
16. Chirieac DV, Collins HL, Cianci J, Sparks JD, Sparks CE: Altered triglyc- eride-rich lipoprotein production in Zucker diabetic fatty rats. Am J Physiol Endocrinol Metab 287:E42-E49, 2004
17. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research, Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ, Hughes TE, Groop L, Altshuler D, Almgren P, Florez JC, Meyer J, Ardlie K, Bengtsson Bostrom K, Isomaa B, Lettre G, Lindblad U, Lyon HN, Melander O, Newton-Cheh C, Nilsson P, Orho-Melander M, Råstam L, Speliotes EK, Traskinen MR, Tuomi T, Guiducci C, Berglund A, Carlson J, Gianniny L, Hackett R, Hall L, Holmkvist J, Laurila E, Sjogren M, Sterner M, Surti A, Svensson M, Svensson M, Tewhey R, Blumenstiel B, Parkin M, Defelice M, Barry R, Brodeur W, Camarata J, Chia N, Fava M, Gibbons J, Handsaker B, Healy C, Nguyen K, Gates C, Sougnez C, Gage D, Nizzari M, Gabriel SB, Chirn GW, Ma Q, Parikh H, Richardson D, Ricke D, Purcell S: Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331-6, 2007
18. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, Strait J, Duren WL, Maschio A, Busonero F, Mulas A, Albai G, Swift AJ, Morken MA, Narisu N, Bennett D, Parish S, Shen H, Galan P, Meneton P, Hercberg S, Zelenika D, Chen WM, Li Y, Scott LJ, Scheet PA, Sundvall J, Watanabe RM, Nagaraja R, Ebrahim S, Lawlor DA, Ben-Shlomo Y, Davey-Smith G, Shuldiner AR, Collins R, Bergman RN, Uda M, Tuomilehto J, Cao A, Collins FS, Lakatta E, Lathrop GM, Boehnke M, Schlessinger D, Mohlke KL, Abecasis GR: Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40:161-169, 2008
19. Vaxillaire M, Cavalcanti-Proencpa C, Dechaume A, Tichet J, Marre M, Balkau B, Froguel P, DESIR Study Group: The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Diabetes 57:2253-2257, 2008
20. Orho-Melander M, Melander O, Guiducci C, Perez-Martinez P, Corella D, Roos C, Tewhey R, Rieder MJ, Hall J, Abecasis G, Tai ES, Welch C, Arnett DK, Lyssenko V, Lindholm E, Saxena R, de Bakker PI, Burtt N, Voight BF, Hirschhorn JN, Tucker KL, Hedner T, Tuomi T, Isomaa B, Eriksson KF, Taskinen MR, Wahlstrand B, Hughes TE, Parnell LD, Lai CQ, Berglund G, Peltonen L, Vartiainen E, Jousilahti P, Havulinna AS, Salomaa V, Nilsson P, Groop L, Altshuler D, Ordovas JM, Kathiresan S: A common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes 57:3112-3121, 2008